Cartesian Therapeutics Inc (RNAC)
25.60
+1.17
(+4.79%)
USD |
NASDAQ |
May 03, 16:00
25.47
-0.13
(-0.51%)
After-Hours: 20:00
Cartesian Therapeutics Total Liabilities (Quarterly): 745.23M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 745.23M |
| September 30, 2023 | 45.70M |
| June 30, 2023 | 74.06M |
| March 31, 2023 | 81.11M |
| December 31, 2022 | 72.06M |
| September 30, 2022 | 93.36M |
| June 30, 2022 | 98.46M |
| March 31, 2022 | 89.93M |
| December 31, 2021 | 137.36M |
| September 30, 2021 | 185.89M |
| June 30, 2021 | 184.74M |
| March 31, 2021 | 196.32M |
| December 31, 2020 | 183.44M |
| September 30, 2020 | 188.38M |
| June 30, 2020 | 88.26M |
| March 31, 2020 | 97.56M |
| December 31, 2019 | 91.17M |
| Date | Value |
|---|---|
| September 30, 2019 | 44.46M |
| June 30, 2019 | 46.89M |
| March 31, 2019 | 47.66M |
| December 31, 2018 | 49.90M |
| September 30, 2018 | 50.32M |
| June 30, 2018 | 49.18M |
| March 31, 2018 | 48.36M |
| December 31, 2017 | 49.29M |
| September 30, 2017 | 44.65M |
| June 30, 2017 | 38.84M |
| March 31, 2017 | 32.77M |
| December 31, 2016 | 34.34M |
| September 30, 2016 | 20.34M |
| June 30, 2016 | 22.54M |
| March 31, 2016 | 20.38M |
| December 31, 2015 | 159.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
44.46M
Minimum
Sep 2019
745.23M
Maximum
Dec 2023
144.44M
Average
93.36M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | 154.14M |
| Adial Pharmaceuticals Inc | 0.6531M |
| Poseida Therapeutics Inc | 170.18M |
| Viracta Therapeutics Inc | 38.37M |
| Biomea Fusion Inc | 33.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 305.05M |
| Shareholders Equity (Quarterly) | -440.18M |
| Current Ratio | 1.330 |
| Net Debt Paydown Yield | 4.68% |